Literature DB >> 14642314

Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans.

Tanja Heintel1, Frank Breinig, Manfred J Schmitt, Andreas Meyerhans.   

Abstract

The human cellular immune response against 14 distantly related yeast species was analyzed by intracellular cytokine staining of lymphocytes after ex vivo stimulation of whole blood. While the CD4 T cell response was marginal, extensive MHC class I-restricted CD8 T cell responses were detected against a number of species including spoiling, environmental and human pathogenic yeasts. The yeast-specific CD8 T cells expressed interferon-gamma but lacked expression of CD27 and CCR7, indicating that they were end-differentiated effector memory cells. Mainly intact yeast cells rather than spheroplasts were able to induce cytokine expression in T cells demonstrating that the dominant immunogens were located in the yeast cell wall. Together these data underline the importance of the cellular immune response in protecting humans against yeast and fungal infections. And, from another perspective, recombinant yeast suggests itself as a potential vaccine candidate to efficiently induce antigen-specific CD8 T cell responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642314     DOI: 10.1016/S0928-8244(03)00294-3

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses.

Authors:  Elizabeth K Wansley; Mala Chakraborty; Kenneth W Hance; Michael B Bernstein; Amanda L Boehm; Zhimin Guo; Deborah Quick; Alex Franzusoff; John W Greiner; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

2.  Human yeast-specific CD8 T lymphocytes show a nonclassical effector molecule profile.

Authors:  Tanja Breinig; Nicoletta Scheller; Birgit Glombitza; Frank Breinig; Andreas Meyerhans
Journal:  Med Microbiol Immunol       Date:  2011-09-25       Impact factor: 3.402

Review 3.  Vaccines based on whole recombinant Saccharomyces cerevisiae cells.

Authors:  Andressa Ardiani; Jack P Higgins; James W Hodge
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

4.  CD8(+) T cells implicated in the pathogenesis of allergic fungal rhinosinusitis.

Authors:  Harshita Pant; Peta Macardle
Journal:  Allergy Rhinol (Providence)       Date:  2014-01

5.  Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice.

Authors:  Lilin Zhang; Lan Yao; Yanyu Guo; Xiaoyang Li; Li Ma; Ruiqi Sun; Xueqing Han; Jing Liu; Jinhai Huang
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 6.064

Review 6.  T cell responses to control fungal infection in an immunological memory lens.

Authors:  Jaishree Sharma; Srinivasu Mudalagiriyappa; Som Gowda Nanjappa
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

7.  Saccharomyces cerevisiae: a versatile eukaryotic system in virology.

Authors:  Rui P Galao; Nicoletta Scheller; Isabel Alves-Rodrigues; Tanja Breinig; Andreas Meyerhans; Juana Díez
Journal:  Microb Cell Fact       Date:  2007-10-10       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.